Literature DB >> 29761280

Adverse effects of media reports on the treatment of osteoporosis.

Cristiana Cipriani1, Jessica Pepe2, Salvatore Minisola2, E Michael Lewiecki3.   

Abstract

PURPOSE: The review focused on the role that media reporting plays in the level of public awareness about osteoporosis and its influence on osteoporosis treatment decisions.
METHODS: We reviewed the literature on the role of media on three main aspects influencing patient adherence to osteoporosis treatment: the awareness of osteoporosis as a major health problem, the perception of the effectiveness of osteoporosis medications, and the fear of adverse effects with osteoporosis medications.
RESULTS: A review of the literature confirmed what is routinely observed in clinical practice-that media report can strongly influence the level of awareness of osteoporosis and fracture risk. Inadequate and/or incorrect information on osteoporosis in the media are associated with a low level of awareness of the disease. High-risk patients may have a poor understanding of the need for treatment. Alarming information in the media over the last 2 decades regarding effectiveness and safety of long-term osteoporosis treatment is associated with reduction in the use of osteoporosis medications.
CONCLUSIONS: There is a gap between the application of clinical recommendations and patient perceptions of osteoporosis and its treatment. There is a need for better education of patients and practitioners aimed at recognizing the serious consequences of fractures and understanding the expected benefits and potential risks of treatment. Media reports that disseminate evidence-based information on the balance of benefits and risks could help to reduce the osteoporosis treatment gap and mitigate the crisis in osteoporosis care.

Entities:  

Keywords:  Fracture; Media; Osteoporosis; Treatment

Mesh:

Substances:

Year:  2018        PMID: 29761280     DOI: 10.1007/s40618-018-0898-9

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  41 in total

1.  Providing health information to women. The role of magazines.

Authors:  C A Moyer; L O Vishnu; S S Sonnad
Journal:  Int J Technol Assess Health Care       Date:  2001       Impact factor: 2.188

2.  Bisphosphonates for osteoporosis--where do we go from here?

Authors:  Marcea Whitaker; Jia Guo; Theresa Kehoe; George Benson
Journal:  N Engl J Med       Date:  2012-05-09       Impact factor: 91.245

3.  Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward.

Authors:  Sundeep Khosla; Jane A Cauley; Juliet Compston; Douglas P Kiel; Clifford Rosen; Kenneth G Saag; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2016-12-29       Impact factor: 6.741

4.  Compliance with osteoporosis medications.

Authors:  Daniel H Solomon; Jerry Avorn; Jeffrey N Katz; Joel S Finkelstein; Marilyn Arnold; Jennifer M Polinski; M Alan Brookhart
Journal:  Arch Intern Med       Date:  2005-11-14

5.  What can we learn from design faults in the Women's Health Initiative randomized clinical trial?

Authors:  Orkun Tan; S Mitchell Harman; Frederick Naftolin
Journal:  Bull NYU Hosp Jt Dis       Date:  2009

6.  Lack of Evidence Linking Calcium With or Without Vitamin D Supplementation to Cardiovascular Disease in Generally Healthy Adults: A Clinical Guideline From the National Osteoporosis Foundation and the American Society for Preventive Cardiology.

Authors:  Stephen L Kopecky; Douglas C Bauer; Martha Gulati; Jeri W Nieves; Andrea J Singer; Peter P Toth; James A Underberg; Taylor C Wallace; Connie M Weaver
Journal:  Ann Intern Med       Date:  2016-10-25       Impact factor: 25.391

Review 7.  Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis.

Authors:  Mark J Bolland; Alison Avenell; John A Baron; Andrew Grey; Graeme S MacLennan; Greg D Gamble; Ian R Reid
Journal:  BMJ       Date:  2010-07-29

8.  Televised medical talk shows--what they recommend and the evidence to support their recommendations: a prospective observational study.

Authors:  Christina Korownyk; Michael R Kolber; James McCormack; Vanessa Lam; Kate Overbo; Candra Cotton; Caitlin Finley; Ricky D Turgeon; Scott Garrison; Adrienne J Lindblad; Hoan Linh Banh; Denise Campbell-Scherer; Ben Vandermeer; G Michael Allan
Journal:  BMJ       Date:  2014-12-17

9.  Poor replication validity of biomedical association studies reported by newspapers.

Authors:  Estelle Dumas-Mallet; Andy Smith; Thomas Boraud; François Gonon
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

10.  The development and validation of an instrument to measure the quality of health research reports in the lay media.

Authors:  Dena Zeraatkar; Michael Obeda; Jeffrey S Ginsberg; Jack Hirsh
Journal:  BMC Public Health       Date:  2017-04-20       Impact factor: 3.295

View more
  7 in total

1.  Patients' reasons for adhering to long-term alendronate therapy.

Authors:  J Pepe; C Cipriani; V Cecchetti; C Ferrara; G Della Grotta; V Danese; L Colangelo; S Minisola
Journal:  Osteoporos Int       Date:  2019-05-14       Impact factor: 4.507

2.  Romosozumab, clinical trials, and real-world care of patients with osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Ann Transl Med       Date:  2020-08

Review 3.  State of the art in osteoporosis risk assessment and treatment.

Authors:  J Liu; E M Curtis; C Cooper; N C Harvey
Journal:  J Endocrinol Invest       Date:  2019-04-12       Impact factor: 4.256

Review 4.  Update on the safety and efficacy of teriparatide in the treatment of osteoporosis.

Authors:  Salvatore Minisola; Cristiana Cipriani; Giada Della Grotta; Luciano Colangelo; Marco Occhiuto; Piergianni Biondi; Chiara Sonato; Evelina Vigna; Mirella Cilli; Jessica Pepe
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-10-05       Impact factor: 5.346

Review 5.  General and Specific Considerations as to why Osteoporosis-Related Care Is Often Suboptimal.

Authors:  Elizabeth M Curtis; Stephen Woolford; Claire Holmes; Cyrus Cooper; Nicholas C Harvey
Journal:  Curr Osteoporos Rep       Date:  2020-02       Impact factor: 5.096

6.  Secondary prevention of fragility fractures: where do we stand during the COVID-19 pandemic?

Authors:  A Falchetti; M Mohseni; F Tramontana; N Napoli
Journal:  J Endocrinol Invest       Date:  2021-04-17       Impact factor: 4.256

7.  Cost-effectiveness of secondary fracture prevention intervention for Medicare beneficiaries.

Authors:  Smita Nayak; Andrea Singer; Susan L Greenspan
Journal:  J Am Geriatr Soc       Date:  2021-08-03       Impact factor: 7.538

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.